NCT03153657View on ClinicalTrials.gov

Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 13, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

May 31, 2017

Conditions
Tooth SensitivityToothache
Interventions
DRUG

Piroxicam-Beta-Cyclodextrin

The patients will receive a single-dose of Piroxicam-Beta-Cyclodextrin (20 mg) thirty minutes before the bleaching procedure.

DRUG

Placebo

The patients will receive a single-dose of placebo with the same presentation of the experimental drug thirty minutes before the bleaching procedure.

Trial Locations (1)

490000

Hospital Universitário - Universidade Federal de Sergipe, Aracaju

All Listed Sponsors
lead

Universidade Federal de Sergipe

OTHER

NCT03153657 - Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching | Biotech Hunter | Biotech Hunter